incretin mimetic agents glp 1 receptor agonists and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease Letter: Association Between Incretin Mimetics

Annals of the New York Academy of Sciences, 387-390

PMID 26187464

PLoS ONE 18(1):e0278685 Ferhatbegovi L, Mri D, Maci-Dankovi A (2023) The benefits of GLP1 receptors in cardiovascular diseases

The long-term use of GLP-1RAs can reduce the risk of MALE in TD patients, thereby improving prognosis

Proc Natl Acad Sci USA 98:23232328 Xu C, Zhang X, Yu C, Lu G, Chen S, Xu L, Ding W, Shi Q, Li Y (2009) Proteomic analysis of hepatic ischemia/reperfusion injury and ischemic preconditioning in mice revealed the protective role of ATP5beta

BPC-157 modulates the nitric oxide system and suppresses specific inflammatory markers at the lesion site